Kristof Vercruysse is the founder of TargED Biopharmaceuticals. TargED Biopharmaceuticals has raised $65M in total funding. Latest round: Series A.
Kristof Vercruysse is the Chief Executive Officer of TargED Biopharmaceuticals, a clinical-stage biotechnology company developing targeted treatments for thrombotic diseases. The company was founded in 2020 as a spin-off from the University Medical Center Utrecht and has raised over €60 million in Series A funding.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide